Anais Brasileiros de Dermatologia (Oct 2016)

Scleromyxedema: clinical diagnosis and autopsy findings

  • Ana Carolina Bulhões Sala,
  • Paulo Rowilson Cunha,
  • Clóvis Antônio Lopes Pinto,
  • Célia Antônia Xavier de Moraes Alves,
  • Ingrid Barreto Paiva,
  • Ana Paula Vieira Araujo

DOI
https://doi.org/10.1590/abd1806-4841.20164527
Journal volume & issue
Vol. 91, no. 5 suppl 1
pp. 48 – 50

Abstract

Read online Read online

Abstract Scleromyxedema is a rare chronic cutaneous mucinosis of unknown etiology. It is characterized by papular eruption and scleroderma with microscopic evidence of mucin deposition, fibroblast proliferation, and fibrosis. Most patients with scleromyxedema have monoclonal gammopathy and systemic manifestations resulting in significant morbidity and mortality. Several types of treatment have been reported with partial or inconsistent responses. Despite showing unpredictable evolution, systemic consequences of scleromyxedema and treatment side effects may result in death. We describe a rare case of a patient with scleromyxedema without paraproteinemia with systemic involvement that evolved to death despite treatment with cyclophosphamide.

Keywords